Article
CYP2C19 gene polymorphism in Ningxia.
Pharmacological reports : PR - 1 Jun 2023
Yang Zhen, Xie Yunqian, Zhang Daya, Zou Yan, Li Ximei, Chen Runxiang, Zhang Xiaodong, Chen Shiju, Bai Feihu
Abstract excerpt
BACKGROUND: Poor metabolizer (PM) status of CYP2C19 can be a predisposing factor for developing gastric cancer in H. pylori-infected patients. It is unclear whether PM status of CYP2C19 can also be a potential factor for H.pylori infection in healthy people. METHODS: We used high-throughput sequencing to detect single nucleotide polymorphisms (SNPs) at just three loci, rs4244285 (CYP2C19*2), rs4986893 (CYP2C19*3)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
